ロード中...
Clinical Characteristics of Korean Patients with Lung Cancer Who Have Programmed Death-Ligand 1 Expression
BACKGROUND: Programmed death-ligand 1 (PD-L1), a transmembrane protein, binds to the programmed death-1 (PD-1) receptor, and anti-PD-1 therapy enables immune responses against tumors. This study aimed to assess clinical characteristics of PD-L1 expression using immunohistochemistry among Korean pati...
保存先:
| 出版年: | Tuberc Respir Dis (Seoul) |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6609527/ https://ncbi.nlm.nih.gov/pubmed/30841018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4046/trd.2018.0070 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|